Calyxt Inc (NASDAQ: CLXT) Announces Hemp Breeding Platform Expansion

July 28, 2021

Calyxt Inc (NASDAQ: CLXT) announced that it started expanding the hemp breeding platform and added triploid breeding technology for creating seedless hemp. The technology company comes with a mission of delivering plant-based innovations to its customers. Earlier in the month, the company said that the new hemp cultivation technology is followed by its announcement of successfully evolving into hemp genome. The advancements like these are a testimony of the company’s…

Read More >>

Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) Receives GMP Certification From Israel

July 28, 2021

Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI), the developer for autologous adult stem cell therapeutics, is known for debilitating neurodegenerative diseases. Yesterday, the leading developer announced that the Israel Ministry of Health granted it Good Manufacturing Practice approval for its second production site. GMP is granted to the company for state-of-the-art cleanrooms in Tel Aviv, Israel. The company has leased the cleanrooms at Sourasky Hospital, or Tel Aviv Sourasky Medical Center. …

Read More >>

Medicenna Therapeutics Corp (NASDAQ: MDNA) Reported Loss of $17.3 Million For The Year Ended March 31, 2021

July 28, 2021

Medicenna Therapeutics Corp (NASDAQ: MDNA) is an immuno-oncology company that announced the financial performance for the year ended March 31, 2021, where the company reported a loss of $17.3 million. In addition, the company guided the way for future growth. Besides this, the company also informed about the MDNA11 phase 1/ 2 study initiation on track. Reported loss; see promising future: During the year ended March 31, 2021, the company…

Read More >>

MyMD Pharmaceuticals Inc (NASDAQ: MYMD) Launching Substitute To JAK Inhibitors

July 28, 2021

MyMD Pharmaceuticals Inc (NASDAQ: MYMD) is focused on developing a couple of therapeutic platforms to provide a healthy lifespan to the patient. The company recently announced the data conducted by Eurofins Discovery indicating similar results between FDA-approved JAK inhibitor drugs and the company clinical compound MYMD-1 to treat autoimmune and inflammatory diseases. MYMD-1 can substitute JAK inhibitor: As per the company, data released by Eurofins Discovery based on the study…

Read More >>

Flotek Industries Inc (NYSE: FTK) To Collaborate With Resolute Oil To Expand Green Chemistry

July 28, 2021

Flotek Industries Inc (NYSE: FTK) is a leading player in a green specialty chemical, serving various industries. The company recently entered into an agreement with Resolute Oil to push the growth in green chemistry markets. Resolute Oil is a leading player in high-quality white mineral oil. Drive growth in green chemistry: As per the management, collaboration with a leading player in white mineral oil will enable the company to drive…

Read More >>

AmmmPowerr Corp (OTCMKTS: AMMPF) Appoints Zhenyu Zhang As Chief Technologist and To Build Ammonia Production Plant In Porto Central

July 27, 2021

AmmmPowerr Corp (OTCMKTS: AMMPF) has announced Dr. Zhenyu Zhang’s appointment as the company’s Chief Technologist. Zhenyu, who attended the Colorado School of Mines, is a catalytic membrane reactors development specialist for effective ammonia decomposition and synthesis.  Zhenyu appointed AmmPower chief technologist  As AmmPower chief technologist, Zhenyu will oversee the development of proprietary ammonia production catalysts tech at the company, such as cracking or hydrogen releasing ammonia dissociation tech. Zhenyu’s position…

Read More >>

Investview Inc. (OTCMKTS: INVU) Reports Record Gross Revenue of $12,9 Million for June Month

July 27, 2021

Investview Inc. (OTCMKTS: INVU) has announced solid consolidated net income and gross revenue for June, contributing to record-breaking quarterly net income and gross revenue for Bitcoin mining and products sales business units.  Investview reported consolidated revenue of $12.9 million  Consolidated gross revenue for June was $12.9 million, which is the second-highest revenue in a month in Investview’s history. The revenue was a 62% month-over-month increase, and net income was $3…

Read More >>

Enzolytics Inc. (OTCMKTS: ENZC) Advancing its ITC-1 Anti-HIV Therapy to Clinical Trials under EMA Across Europe

July 27, 2021

Enzolytics Inc. (OTCMKTS: ENZC) has finalized plans to advance the previously tested ITV-1 anti-HIV treatment to clinical studies and supply across Europe. Completing the steps will establish the anti-HIV therapy as a potential revenue source, a significant milestone for Enzolytics’ profitability and human health.  Anti-HIV therapy progressing to clinical studies under EMA The anti-HIV therapy had progressed toward Bulgarian Drug Agency certification, but the process was halted before completion. But,…

Read More >>

OPTEC International Inc. (OTCMKTS: OPTI) Announce Partnership with Solteir For Green BTC Mining

July 27, 2021

OPTEC International Inc. (OTCMKTS: OPTI) has entered a renewable energy mining partnership with BTC mining company Solteir and its co-founders Andrew Insignares and Jesse Fastenberg following the recent disruption of mining in Miami.  OPTEC International partners with Solteir The test program will utilize OPTEC International’s Solar Panelled Generators in mining BTC at Solteir’s mining facility located in Bradford County, Pennsylvania, with operations expected to commence in the early fall of…

Read More >>

Nutra Pharma Corporation (OTCMKTS: NPHC) Announces Availability of Nyloxin at Diverse Health Services

July 27, 2021

Nutra Pharma Corporation (OTCMKTS: NPHC) has announced the addition of the Nyloxin product line to Metro-Detroit’s Diverse Health Services’ offerings. Already Nyloxin is being offered in-house at the Diverse health Services’ facilities and will now be included on the online marketplace.  Nyloxin available at Diverse Health facilities  The marketing plan involves direct patient sales and other facilities, videos that will feature Dr. R.E Tent, and sales via social media and…

Read More >>